INTERNATIONAL PATENT: BIAL - PORTELA & CA., S.A. FILES APPLICATION FOR "GENE THERAPY FOR TREATMENT OF SYNGAP1-RELATED EPILEPTIC ENCEPHALOPATHY"

GENEVA, Jan. 20 -- BIAL - PORTELA & CA., S.A. (A Avenida da Siderurgia Nacional4745-457 Coronado (S. Romão e S. Mamede)) filed a patent application (PCT/PT2025/050016) for "GENE THERAPY FOR TREATMENT OF SYNGAP1-RELATED EPILEPTIC ENCEPHALOPATHY" on Jul 08, 2025. With publication no. WO/2026/015039, the details related to the patent application was published on Jan 15, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JAGADISH, Smitha (c/o BIAL - PORTELA & CA., S.A.A Avenida da Siderurgia Nacional4745-457 Coronado (S. Romão e S. Mamede))

Abstract: The present disclosure describes reco...